Skip to main content
SpringerLink
Log in

Endothelial dysfunction, inflammation, and insulin resistance: A focus on subjects at risk for type 2 diabetes

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Subjects with obesity, family history of type 2 diabetes, polycystic ovary syndrome, previous gestational diabetes, dyslipidemia, hypertension, impaired glucose tolerance or impaired fasting glucose, and those with metabolic syndrome are at risk for the development of type 2 diabetes. Some of them are also at risk for cardiovascular disease. Some underlying abnormalities such as insulin resistance, endothelial dysfunction, and low-grade chronic inflammation are frequently present and closely associated in all these groups. The flow of substrates, hormones, and cytokines from visceral fat to skeletal muscle and to the endothelial cells, along with some genetic abnormalities that lead to impaired insulin action in the peripheral tissues and to impaired insulin-stimulated nitric oxide production in endothelial cells, may play a role in establishing these shared metabolic and vascular derangements. Weight loss, thiazolidinediones, and metformin improve vascular function in subjects at risk for type 2 diabetes and may prove to reduce cardiovascular events in these individuals.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. King GL, Wakasaki H: Theoretical mechanisms by which hyperglycemia and insulin resistance could cause cardiovascular diseases in diabetes. Diabetes Care 1999, 22:C31-C37.

    PubMed  Google Scholar 

  2. Pyorala M, Miettinen H, Halonen P, et al.: Insulin resistance syndrome predicts the risk of coronary heart disease and stroke in healthy middle-aged men: the 22-year follow-up results of the Helsinki Policemen Study. Arterioscler Thromb Vasc Biol 2000, 20:538–544.

    PubMed  CAS  Google Scholar 

  3. Hu FB, Stampfer MJ, Haffner SM, et al.: Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2 diabetes. Diabetes Care 2002, 25:1129–1134.

    Article  PubMed  Google Scholar 

  4. Pyorala M, Miettinen H, Laakso M, Pyorala K: Plasma insulin and all-cause, cardiovascular, and noncardiovascular mortality: the 22-year follow-up results of the Helsinki Policemen Study. Diabetes Care 2000, 23:1097–1102.

    Article  PubMed  CAS  Google Scholar 

  5. Hanley AJ, Williams K, Stern MP, Haffner SM: Homeostasis Model Assessment of insulin resistance in relation to the incidence of cardiovascular disease: the San Antonio Heart Study. Diabetes Care 2002, 25:1177–1184.

    Article  PubMed  Google Scholar 

  6. Steinberg HO, Chaker H, Leaming R, et al.: Obesity/insulin resistance is associated with endothelial dysfunction. J Clin Invest1996, 97:2601–2610.

    PubMed  CAS  Google Scholar 

  7. Caballero AE: Endothelial dysfunction in obesity and insulin resistance: a road to diabetes and heart disease. Obes Res 2003, 11:1278–1289. Updated review of the mechanisms that link obesity, insulin resistance, and endothelial dysfunction.

    PubMed  CAS  Google Scholar 

  8. Gerich JE: Contributions of insulin-resistance and insulinsecretory defects to the pathogenesis of type 2 diabetes mellitus. Mayo Clin Proc 2003, 78:411–413.

    Article  Google Scholar 

  9. Urrutia-Rojas X, Menchaca J, Wadley W, et al.: Cardiovascular risk factors in Mexican-American children at risk for type 2 diabetes mellitus. J Adolesc Health 2004, 34:290–299.

    Article  PubMed  Google Scholar 

  10. Goldfine AB, Bouche C, Parker RA, et al.: Insulin resistance is a poor predictor of type 2 diabetes in individuals with no family history of disease. Proc Natl Acad Sci U S A 2003, 100:2724–2729.

    Article  PubMed  CAS  Google Scholar 

  11. American Diabetes Association: Screening for type 2 diabetes. Diabetes Care 2004, 27(suppl 1):S11-S14.

    Google Scholar 

  12. Grundy SM, Hansen B, Smith SC, et al.: Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung and Blood Institute/ American Diabetes Association conference on scientific issues related to management. Circulation 2004, 109:551–556.

    Article  PubMed  Google Scholar 

  13. Vane JR, Anggard EE, Botting RM: Regulatory functions of the vascular endothelium. N Engl J Med 1990, 323:27–36.

    Article  PubMed  CAS  Google Scholar 

  14. Libby P, Ridker PM, Maseri A: Inflammation and atherosclerosis. Circulation 2002, 105:1135–1143. Important review of why atherosclerosis is considered an inflammatory disease.

    Article  PubMed  CAS  Google Scholar 

  15. Saouf R, Arora S, Smakowski P, et al.: Reactive hyperemic response of the brachial artery to proximal and distal occlusion. Acad Radiol 1998, 5:566–560.

    Google Scholar 

  16. Corretti MC, Anderson TJ, Benjamin EJ, et al.: Guidelines for the ultrasound assessment of endothelial-dependent flow mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 2002, 39:257–265. The most updated paper on the high-resolution ultrasound technique as a method for the assessment of vascular reactivity and endothelial function in the brachial artery.

    Article  PubMed  Google Scholar 

  17. Halcox JP, Schenke WH, Zalos G, et al.: Prognostic value of coronary vascular endothelial dysfunction. Circulation 2002, 106:653–658.

    Article  PubMed  Google Scholar 

  18. Gokce N, Keaney JF Jr, Hunter LM, et al.: Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease. J Am Coll Cardiol2003, 41:1769–1775.

    Article  PubMed  Google Scholar 

  19. Lim SC, Caballero AE, Smakowski P, et al.: Soluble intercellular adhesion molecule, vascular cell adhesion molecule, and impaired microvascular reactivity are early markers of vasculopathy in type 2 diabetic individuals without microalbuminuria. Diabetes Care 1999, 22:1865–1870.

    Article  PubMed  CAS  Google Scholar 

  20. Hwang SJ, Balantyne CM, Sharrett R, et al.: Circulating adhesion molecules VCAM-1, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. The atherosclerosis risk in communities (ARIC) study. Circulation 1997, 96:4219–4225.

    PubMed  CAS  Google Scholar 

  21. Ridker PM, Rifai N, Rose L, et al.: Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events. N Engl J Med2002, 347:1557–1565.

    Article  PubMed  CAS  Google Scholar 

  22. Meigs JB, Hu FB, Rifai N, Manson JE: Biomarkers of endothelial dysfunction and risk of type 2 diabetes mellitus. JAMA 2004, 291:1978–1986.

    Article  PubMed  CAS  Google Scholar 

  23. Tounian P, Aggoun Y, Dubern B, et al.: Presence of increased stiffness of the common carotid artery and endothelial dysfunction in severely obese children: a prospective study. Lancet 2001, 358:1400–1404.

    Article  PubMed  CAS  Google Scholar 

  24. Festa A, D'Agostino RJ, Howard G, et al.: Chronic subclinical inflammation as part of the insulin resistance syndrome: the Insulin Resistance Atherosclerosis Study (IRAS). Circulation 2000, 102:42–47.

    PubMed  CAS  Google Scholar 

  25. Vigili de Kreutzenberg S, Kiwanuka E, Tiengo A, Avogaro A: Visceral obesity is characterized by impaired nitric oxideindependent vasodilation. Eur Heart J 2003, 24:1210–1215.

    Article  PubMed  CAS  Google Scholar 

  26. Griffin ME, Marcucci MJ, Cline GW, et al.: Free fatty acidinduced insulin resistance is associated with activation of protein kinase C theta and alterations in the insulin signaling cascade. Diabetes 1999, 48:1270–1274.

    Article  PubMed  CAS  Google Scholar 

  27. Steinberg HO, Baron AD: Vascular function, insulin resistance and fatty acids. Diabetologia 2002, 45:623–634.

    Article  PubMed  CAS  Google Scholar 

  28. Hotamisligil GS: The role of TNF-alpha and TNF receptors in obesity and insulin resistance. J Intern Med 1999, 245:621–625.

    Article  PubMed  CAS  Google Scholar 

  29. Winkler G, Lakatos P, Salamon F, et al.: Elevated serum TNF-alpha level as a link between endothelial dysfunction and insulin resistance in normotensive obese patients. Diabet Med 1999, 16:207–211.

    Article  PubMed  CAS  Google Scholar 

  30. Yudkin JS, Kumari M, Humphries SE, Mohamed-Ali V: Inflammation, obesity, stress and coronary heart disease: is interleukin-6 the link? Atherosclerosis 2002, 148:209–214.

    Article  Google Scholar 

  31. Jialal I, Devaraj S, Venugopal SK: C-reactive protein: risk marker or mediator in atherothrombosis? Hypertension 2004, in press.

  32. Kim YB, Uotani S, Perroz DD, et al.: In vivo administration of leptin activates signal transduction directly in insulin sensitive tissues: overlapping but distinct pathways from insulin. Endocrinology 2000, 141:2328–2339.

    Article  PubMed  CAS  Google Scholar 

  33. Lembo G, Vecchione C, Fratta L, et al.: Leptin induces direct vasodilation through distinct endothelial mechanisms. Diabetes2000, 49:293–297.

    Article  PubMed  CAS  Google Scholar 

  34. Steppan CM, Bailey ST, Bhat S, et al.: The hormone resistin links obesity to diabetes. Nature 2001, 409:307–312.

    Article  PubMed  CAS  Google Scholar 

  35. Yamauchi T, Kamon J, Ito Y, et al.: Cloning of adiponectin receptors that mediate antidiabetic metabolic effects. Nature 2003, 423:762–769.

    Article  PubMed  CAS  Google Scholar 

  36. Chen H, Montagnani M, Funahashi T, et al.: Adiponectin stimulates production of nitric oxide in vascular endothelial cells. J Biol Chem 2003, 278:45021–45026.

    Article  PubMed  CAS  Google Scholar 

  37. Caballero AE, Arora S, Saouaf R, et al.: Micro and macrovascular reactivity is reduced in subjects at risk for type 2 diabetes. Diabetes 1999, 48:1856–1862.

    Article  PubMed  CAS  Google Scholar 

  38. Balletshofer BM, Rittig K, Enderle MD, et al.: Endothelial dysfunction is detectable in young normotensive first-degree relatives of subjects with type 2 diabetes in association with insulin resistance. Circulation 2000, 101:1780–1784.

    PubMed  CAS  Google Scholar 

  39. Goldfine A, Beckman J, Devlin H, et al.: The role of a family history of diabetes on endothelial function. J Am Coll Cardiol 2004, 43:468A.

    Article  Google Scholar 

  40. Gaeta G, De Michelle M, Guomo S, et al.: Arterial abnormalities in the offspring of patients with premature myocardial infarction. N Engl J Med 2000, 343:840–846.

    Article  PubMed  CAS  Google Scholar 

  41. Pannacciulli N, De Pergola G, Giorgino F, Giorgino R: A family history of type 2 diabetes is associated with increased plasma levels of C-reactive protein in non-smoking healthy adult women. Diabet Med 2002, 19:689–692.

    Article  PubMed  CAS  Google Scholar 

  42. Paradisi G, Steinberg HO, Hempfling A, et al.: Polycystic ovary syndrome is associated with endothelial dysfunction. Circulation 2001, 103:1410–1415.

    PubMed  CAS  Google Scholar 

  43. Mather KJ, Verma S, Corenblum B, Anderson TJ: Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome. J Clin Endocrinol Metab 2000, 85:1851–1856.

    Article  PubMed  CAS  Google Scholar 

  44. Kelly CC, Lyall H, Petrie JR, et al.: Low grade chronic inflammation in women with polycystic ovarian syndrome. J Clin Endocrinol Metab 2001, 86:2453–2455.

    Article  PubMed  CAS  Google Scholar 

  45. Talbott EO, Guzick DS, Sutton-Tyrrell K, et al.: Evidence for association between polycystic ovary syndrome and premature carotid atherosclerosis in middle-aged women. Arterioscler Thromb Vasc Biol 2000, 20:2414–2421.

    PubMed  CAS  Google Scholar 

  46. Anastasiou E, Leakakis JP, Alevizaki M, et al.: Impaired endothelium-dependent vasodilatation in women with previous gestational diabetes. Diabetes Care 1998, 21:2111–2115.

    Article  PubMed  CAS  Google Scholar 

  47. Hannemann MM, Liddell WG, Shore AC, et al.: Vascular function in women with previous gestational diabetes. J Vasc Res 2002, 39:311–319.

    Article  PubMed  Google Scholar 

  48. Bergholm R, Tiikkainen M, Venkavaara S, et al.: Lowering LDL cholesterol rather than moderate weight loss improves endothelium-dependent vasodilation in obese women with previous gestational diabetes. Diabetes Care 2003, 26:1667–1672.

    Article  PubMed  CAS  Google Scholar 

  49. Lekakis JP, Anastasiou EA, Papamichael CM, et al.: Shortterm oral ascorbic acid improves endothelium-dependent vasodilation in women with a history of gestational diabetes mellitus. Diabetes Care 2000, 23:1432–1434.

    Article  PubMed  CAS  Google Scholar 

  50. DPP Research Group: The effect of lifestyle modification and metformin on markers CRP, fibrinogen and tPA in the DPP. Diabetes 2003, 52(suppl 1):A79. First results of the DPP in regard to the effect of lifestyle modification and metformin on markers of endothelial function and inflammation.

    Google Scholar 

  51. Esposito K, Nappo F, Marfella R, et al.: Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation 2002, 106:2067–2072.

    Article  PubMed  CAS  Google Scholar 

  52. Vehkavaara S, Seppala-Lindroos A, Westerbacka J, et al.: In vivo endothelial dysfunction characterizes patients with impaired fasting glucose. Diabetes Care 1999, 22:2055–2060.

    Article  PubMed  CAS  Google Scholar 

  53. Lind L: Lipids and endothelium dependent vasodilation-a review. Lipids 2002, 37:1–15.

    Article  PubMed  CAS  Google Scholar 

  54. Ferri C, Desideri G, Baldoncini R, et al.: Early activation of vascular endothelium in nonobese, nondiabetic essential hypertensive patients with multiple metabolic abnormalities. Diabetes 1998, 47:660–667.

    Article  PubMed  CAS  Google Scholar 

  55. Ninomiya JK, L'Italien G, Criqui MH, et al.: Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004, 109:42–46.

    Article  PubMed  Google Scholar 

  56. Kuboki K, Jiang ZY, Takahara N, et al.: Regulation of endothelial constitutive nitric oxide synthase gene expression in endothelial cells in vivo: a specific vascular action of insulin. Circulation 2000, 101:676–681.

    PubMed  CAS  Google Scholar 

  57. Cusi K, Maezono K, Osman A, et al.: Insulin resistance differentially affects the PI-3-kinase and MAP kinase mediated signaling in human muscle. J Clin Invest 2000, 105:311–320.

    PubMed  CAS  Google Scholar 

  58. Hsueh WA, Quinones M: Role of endothelial dysfunction in insulin resistance. Am J Cardiol 2003, 92(suppl):10J-17J.

    Article  PubMed  CAS  Google Scholar 

  59. Jiang ZY, Lin YW, Clemont A, et al.: Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats. J Clin Invest 1999, 104:447–457.

    Article  PubMed  CAS  Google Scholar 

  60. Arora S, Veves A, Caballero AE, et al.: Estrogen improves endothelial function. J Vasc Surg 1998, 27:1141–1147.

    Article  PubMed  CAS  Google Scholar 

  61. Lim SC, Caballero AE, Arora S, et al.: The effect of hormonal replacement therapy on the vascular reactivity and endothelial function of healthy individuals and individuals with type 2 diabetes. J Clin Endocrinol Metab 1999, 84:4159–4164.

    Article  PubMed  CAS  Google Scholar 

  62. Hamdy O, Ledbury S, Mullooly C, et al.: Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 2003, 26:2110–2125.

    Article  Google Scholar 

  63. Nicklas BJ, Ambrosius W, Messier SP, et al.: Diet-induced weight loss, exercise and chronic inflammation in older, obese adults: a randomized controlled clinical trial. Am J Clin Nutr 2004, 79:544–551.

    PubMed  CAS  Google Scholar 

  64. Woo KS, Chook P, Yu CW, et al.: Effects of diet and exercise on obesity-related vascular dysfunction in children. Circulation 2004, 27:1981–1986.

    Article  Google Scholar 

  65. Raitakari M, Ilvonen T, Ahotupa M, et al.: Weight reduction with very low caloric diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler Thromb Vasc Biol 2004, 24:124–128.

    Article  PubMed  CAS  Google Scholar 

  66. Hsueh W, Bruemmer D: Peroxisome proliferator-activated receptor g: implications for cardiovascular disease. Hypertension 2004, 43:297–305. Updated review of the effects of TZDs on vascular function and the implications for the prevention or amelioration of cardiovascular disease.

    Article  PubMed  CAS  Google Scholar 

  67. Plutzky J: The potential role of peroxisome prolifertoractivated receptors on inflammation in type 2 diabetes mellitus and atherosclerosis. Am J Cardiol 2003, 92(suppl):34J-41J.

    Article  PubMed  CAS  Google Scholar 

  68. Caballero AE, Saouaf R, Lim SC, et al.: The effects of troglitazone on the endothelial function of the micro- and macrocirculation in patients with early and late type 2 diabetes. Metabolism 2003, 52:173–180.

    Article  PubMed  CAS  Google Scholar 

  69. Dandona P, Aljada A, Chaudhuri A: Vascular reactivity and thiazolidinediones. Am J Med 2003, 115:81S-86S.

    Article  PubMed  CAS  Google Scholar 

  70. Charles MA, Morange P, Eschwege E, et al.: Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity. Diabetes Care 1998, 21:1967–1972.

    Article  PubMed  CAS  Google Scholar 

  71. Caballero AE, Delgado A, Naranjo A, et al.: Metformin improves markers of endothelial activation but not markers of inflammation in subjects with impaired glucose tolerance. J Clin Endocrinol Metab 2004, in press.

Download references

Author information

Authors and Affiliations

  1. Latino Diabetes Initiative, Joslin Diabetes Center, Harvard Medical School, One Joslin Place, 02215, Boston, MA, USA

    A. Enrique Caballero MD

Authors
  1. A. Enrique Caballero MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Caballero, A.E. Endothelial dysfunction, inflammation, and insulin resistance: A focus on subjects at risk for type 2 diabetes. Curr Diab Rep 4, 237–246 (2004). https://doi.org/10.1007/s11892-004-0074-9

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-004-0074-9

Keywords

Search

Navigation